InsidersTradesSigma
Track the Edesa Biotech, Inc. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Edesa Biotech, Inc. has logged 93 insider filings. Market capitalisation: €50.4m. The latest transaction was filed on 4 August 2026 (Attribution). Among the most active insiders: Nijhawan Pardeep. The full history is accessible without an account.
93
Insider Decl.
n/a
Thresholds
€265,322
25 ops.
Buy Volume
€331,866
1 ops.
Sell Volume
38Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 August 2026
Declarations93 total
5,324 shares0Common SharesSEC:0001171843-26-005208:0
153,530 shares@ CA$5.210.93% mcap100.0% of flowCommon SharesTSXSEDI:4736614
Canonical exit: 14 Sept 2026 (T+90)
153,550 sharesCommon SharesSEC:0001171843-26-004151:0
64,609 sharesRestricted Share UnitsTSXSEDI:4726433
19,000 sharesRestricted Share UnitsTSXSEDI:4726284
19,000 sharesRestricted Share UnitsTSXSEDI:4726278
19,000 sharesRestricted Share UnitsTSXSEDI:4726250
64,609 sharesRestricted Share UnitsTSXSEDI:4726240
96,913 sharesRestricted Share UnitsTSXSEDI:4726235
19,000 sharesRestricted Share UnitsTSXSEDI:4726229
19,000 sharesRestricted Share UnitsTSXSEDI:4726226
19,000 sharesRestricted Share UnitsTSXSEDI:4726223
1,671 shares0Common SharesSEC:0001171843-26-003842:0
64,609 shares0Common SharesSEC:0001171843-26-003801:0
19,000 shares0Common SharesSEC:0001171843-26-003803:0
19,000 shares0Common SharesSEC:0000921895-26-001502:0
96,913 shares0Common SharesSEC:0001171843-26-003797:0
19,000 shares0Common SharesSEC:0001171843-26-003799:0
19,000 shares0Common SharesSEC:0001171843-26-003800:0
64,609 shares0Common SharesSEC:0001171843-26-003802:0
19,000 shares0Common SharesSEC:0001171843-26-003804:0
19,000 shares0Common SharesSEC:0001171843-26-003805:0
1,159 shares0Common SharesSEC:0001171843-26-002942:0
2,578 shares0Common SharesSEC:0001171843-26-002373:0
2,000 shares@ US$1.578.4% of flowCommon SharesSEC:0001171843-26-001490:0
Canonical exit: 27 May 2026 (T+90)
25 of 93 declarations
About Edesa Biotech, Inc.
Edesa Biotech, Inc. is a company focused on developing treatments for inflammatory diseases and dermatological disorders. It is listed on NASDAQ under the ticker EDSA.